Commerzbank Aktiengesellschaft’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $493K | Hold |
918
| – | – | 0.01% | 245 |
|
|
2025
Q1 | $386K | Hold |
918
| – | – | 0.01% | 260 |
|
|
2024
Q4 | $379K | Buy |
918
+262
| +40% | +$108K | 0.01% | 249 |
|
|
2024
Q3 | $332K | Buy |
656
+134
| +26% | +$67.8K | 0.01% | 231 |
|
|
2024
Q2 | $255K | Sell |
522
-96
| -16% | -$46.9K | 0.01% | 214 |
|
|
2024
Q1 | $334K | Buy |
618
+100
| +19% | +$54K | 0.01% | 191 |
|
|
2023
Q4 | $288K | Buy |
+518
| New | +$288K | 0.01% | 164 |
|
|
2020
Q1 | – | Sell |
-5,877
| Closed | -$1.54M | – | 510 |
|
|
2019
Q4 | $1.54M | Sell |
5,877
-437
| -7% | -$114K | 0.01% | 373 |
|
|
2019
Q3 | $1.72M | Buy |
6,314
+4,242
| +205% | +$1.15M | 0.01% | 436 |
|
|
2019
Q2 | $570K | Buy |
+2,072
| New | +$570K | ﹤0.01% | 598 |
|
|
2019
Q1 | – | Sell |
-1,489
| Closed | -$277K | – | 777 |
|
|
2018
Q4 | $277K | Sell |
1,489
-16,395
| -92% | -$3.05M | ﹤0.01% | 683 |
|
|
2018
Q3 | $4.47M | Buy |
17,884
+15,622
| +691% | +$3.9M | 0.04% | 299 |
|
|
2018
Q2 | $493K | Sell |
2,262
-3,577
| -61% | -$780K | ﹤0.01% | 632 |
|
|
2018
Q1 | $1.12M | Sell |
5,839
-1,159
| -17% | -$222K | 0.01% | 495 |
|
|
2017
Q4 | $1.09M | Buy |
6,998
+3,093
| +79% | +$484K | 0.01% | 480 |
|
|
2017
Q3 | $607K | Buy |
+3,905
| New | +$607K | 0.01% | 540 |
|
|
2017
Q2 | – | Sell |
-4,149
| Closed | -$641K | – | 755 |
|
|
2017
Q1 | $641K | Sell |
4,149
-1,549
| -27% | -$239K | 0.01% | 562 |
|
|
2016
Q4 | $668K | Buy |
5,698
+1,791
| +46% | +$210K | 0.01% | 503 |
|
|
2016
Q3 | $440K | Sell |
3,907
-1,123
| -22% | -$126K | 0.01% | 584 |
|
|
2016
Q2 | $467 | Buy |
+5,030
| New | +$467 | ﹤0.01% | 679 |
|
|
2014
Q1 | – | Sell |
-10,292
| Closed | -$588K | – | 1139 |
|
|
2013
Q4 | $588K | Buy |
10,292
+498
| +5% | +$28.5K | ﹤0.01% | 862 |
|
|
2013
Q3 | $488K | Sell |
9,794
-138
| -1% | -$6.88K | ﹤0.01% | 865 |
|
|
2013
Q2 | $445K | Buy |
+9,932
| New | +$445K | ﹤0.01% | 950 |
|